Toxicity of topical anesthetic agents to human keratocytes in vivo.

PURPOSE To test the potential toxicity on human keratocytes of topical anesthetic agents used after photorefractive keratectomy (PRK) to reduce or eliminate pain. SETTING Department of Ophthalmology, Doheny Eye Institute, University of Southern California, Los Angeles, California, USA. METHODS Cultured human keratocytes were incubated with commercially available tetracaine and proparacaine at reduced concentrations of 0.001%, 0.01%, 0.1%, and 0.25%. Evaluations were performed by phase-contrast microscopy and tetrazolium salt colorimetric assay every 2 hours for 12 hours after adding 1 of the anesthetic agents to the media. RESULTS After time of incubation and concentration were adjusted, both drugs reduced overall cell viability; however, tetracaine produced a larger decrease in cell viability than proparacaine (P = .008). For both drugs, significant differences were found among concentrations for and across time (P < .001 and P = .004, respectively). CONCLUSION Both tetracaine and proparacaine had toxic effects on stromal keratocytes related not only to drug concentrations but also to time exposure. These findings underscore the widespread concern that anesthetic drugs may affect corneal stromal wound healing after PRK.

[1]  J. Marshall,et al.  A prospective, randomized, double-masked trial to evaluate the role of topical anesthetics in controlling pain after photorefractive keratectomy. , 1995, Ophthalmology.

[2]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[3]  G. Kolar,et al.  Toxic side effects of local anaesthetics on the human cornea. , 1994, The British journal of ophthalmology.

[4]  J Wollensak,et al.  Myopic photorefractive keratectomy with the excimer laser. One-year follow-up. , 1991, Ophthalmology.

[5]  J. Marshall,et al.  Control of pain after photorefractive keratectomy. , 1996, Journal of refractive surgery.

[6]  G. Rocha,et al.  Severe toxic keratopathy secondary to topical anesthetic abuse. , 1995, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[7]  W. Culbertson,et al.  Topical anesthetic abuse. , 1990, Ophthalmology.

[8]  N. Raccio-Robak,et al.  A comparison of proparacaine and tetracaine eye anesthetics. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[9]  S A Arshinoff,et al.  Pharmacotherapy of photorefractive keratectomy , 1996, Journal of cataract and refractive surgery.

[10]  Y. Gordon,et al.  Comparative tear concentrations over time of ofloxacin and tobramycin in human eyes , 1994, Clinical pharmacology and therapeutics.

[11]  D. Acosta,et al.  Comparative toxicity of tetracaine, proparacaine and cocaine evaluated with primary cultures of rabbit corneal epithelial cells. , 1994, Experimental eye research.

[12]  N. Burstein Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. , 1980, Survey of ophthalmology.

[13]  A. Gasset,et al.  Cytotoxicity of ophthalmic preservatives. , 1974, American journal of ophthalmology.

[14]  D. Acosta,et al.  A digitized fluorescence imaging study on the effects of local anesthetics on cytosolic calcium and mitochondrial membrane potential in cultured rabbit corneal epithelial cells. , 1994, Toxicology and Applied Pharmacology.